ahlam1399
09-16-2016, 11:43 PM
**vartis says experimental drug helps chronic mi*****e sufferers
ZURICH (Reuters) - About 40 percent of chronic mi*****e sufferers taking an experimental drug developed by **vartis and Amgen saw the number of days they suffered a mi*****e cut by at least half, beating the placebo in the trial.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=9NGZeo8MGLo:csZ6EGX-Md0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=9NGZeo8MGLo:csZ6EGX-Md0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=9NGZeo8MGLo:csZ6EGX-Md0:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=9NGZeo8MGLo:csZ6EGX-Md0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=9NGZeo8MGLo:csZ6EGX-Md0:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/9NGZeo8MGLo
ZURICH (Reuters) - About 40 percent of chronic mi*****e sufferers taking an experimental drug developed by **vartis and Amgen saw the number of days they suffered a mi*****e cut by at least half, beating the placebo in the trial.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=9NGZeo8MGLo:csZ6EGX-Md0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=9NGZeo8MGLo:csZ6EGX-Md0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=9NGZeo8MGLo:csZ6EGX-Md0:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=9NGZeo8MGLo:csZ6EGX-Md0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=9NGZeo8MGLo:csZ6EGX-Md0:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/9NGZeo8MGLo